Browsing by Author An, Tongtong

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 20 of 59 next >
Issue Date Title Author(s)
2019 ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane-based chemotherapy Zhong, Jia;Guo, Zihan;Fang, Liping;Zhao, Xinghui;Zhao, Bingqing;Cao, Zhigang;Cheng, Linlin;Shia, Yuanyuan;Li, Xiaoting;Zhang, Yanhua;An, Tongtong;Wu, Meina;Wang, Yuyan;Zhu, Minglei;Li, Jianjie;Yang, Xue;Chen, Hanxiao;Jia, Bo;Zhao, Jun
2013 Alterations in EGFR and Related Genes following Neo-Adjuvant Chemotherapy in Chinese Patients with Non-Small Cell Lung Cancer Wang, Shuhang;An, Tongtong;Duan, Jianchun;Zhang, Lijian;Wu, Meina;Zhou, Qinghua;Chen, Jinfeng;Zhuo, Minglei;Yang, Lu;Wang, Yuyan;Bai, Hua;Wang, Jie
2018 Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancer Lv, Chunxin;Liu, Xiuju;Zheng, Qiwen;Chen, Hanxiao;Yang, Xue;Zhong, Jia;Wang, Yuyan;Duan, Jianchun;Wang, Zhijie;Bai, Hua;Wu, Meina;Zhao, Jun;Wang, Jie;Wang, Ziping;An, Tongtong;Zhuo, Minglei
16-Jul-2020 Clinical Characteristics and Outcomes of Patients With Primary Mediastinal Germ Cell Tumors: A Single-Center Experience Wang, Lu;Zhao, Jun;An, Tongtong;Wang, Yuyan;Zhuo, Minglei;Wu, Meina;Wang, Ziping;Li, Jianjie;Yang, Xue;Chen, Hanxiao;Zhong, Jia
2013 Clinical features of patients with lung adenocarcinomas harboring BRAF V600E mutations An, Tongtong;Wang, Jie;Bai, Hua;Wang, Zhijie;Zhao, Jun;Duan, Jianchun;Zhuo, Minglei;Wu, Meina;Wang, Yuyan;Wang, Shuhang
2016 Clinical outcome of epidermal growth factor receptor-tyrosine kinase inhibitors therapy for patients with overlapping kirsten rat sarcoma 2 viral oncogene homolog and epidermal growth factor receptor gene mutations Zhang, Hong;Bai, Hua;Yang, Xiaodan;Zhong, Jia;An, Tongtong;Zhao, Jun;Wang, Jie
2017 Comprehensive Analysis of the Discordance of EGFR Mutation Status between Tumor Tissues and Matched Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer Wan, Rui;Wang, Zhijie;Lee, J. Jack;Wang, Shuhang;Li, Qingqing;Tang, Fuchou;Wang, Jin;Sun, Yu;Bai, Hua;Wang, Di;Zhao, Jun;Duan, Jianchun;Zhuo, Minglei;An, Tongtong;Wu, Meina;Chen, Zhaoli;Yang, Zhenlin;Wang, Jie
2013 Cytoplasmic ER beta expression to predict efficacy and survival of EGFR-TKI in EGFR-mutant NSCLC Wang, Zhijie;Wang, Jie;Wang, Xiaodong;Shen, Zhirong;Ding, Xiaosheng;Bai, Hua;Duan, Jianchun;An, Tongtong;Wang, Yuyan;Zhuo, Minglei;Wang, Shuhang;Wu, Meina
2013 Detection and Clinical Significance of Intratumoral EGFR Mutational Heterogeneity in Chinese Patients with Advanced Non-Small Cell Lung Cancer Bai, Hua;Wang, Zhijie;Wang, Yuyan;Zhuo, Minglei;Zhou, Qinghua;Duan, Jianchun;Yang, Lu;Wu, Meina;An, Tongtong;Zhao, Jun;Wang, Jie
2012 The detection of EGFR mutation status in plasma is reproducible and can dynamically predict the efficacy of EGFR-TKI Huang, Zhen;Wang, Zhijie;Bai, Hua;Wu, Meina;An, Tongtong;Zhao, Jun;Yang, Lu;Duan, Jianchun;Zhuo, Minglei;Wang, Yuyan;Wang, Shuhang;Wang, Jie
2018 Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial Wang, Zhijie;Cheng, Ying;An, Tongtong;Gao, Hongjun;Wang, Kai;Zhou, Qing;Hu, Yanping;Song, Yong;Ding, Cuimin;Peng, Feng;Liang, Li;Hu, Yi;Huang, Cheng;Zhou, Caicun;Shi, Yuankai;Zhang, Li;Ye, Xin;Zhang, Meizhuo;Chuai, Shaokun;Zhu, Guanshan;Hu, Jin;Wu, Yi-long;Wang, Jie
2012 DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer Zhu, Jian;Wang, Yuyan;Duan, Jianchun;Bai, Hua;Wang, Zhijie;Wei, Lai;Zhao, Jun;Zhuo, Minglei;Wang, Shuhang;Yang, Lu;An, Tongtong;Wu, Meina;Wang, Jie
2013 DYNAMIC, QUANTITATIVE, AND NON-INVASIVE ANALYSIS OFT790M MUTATION IN MATCHED PLASMA DNA FROM PRE-AND POST-EGFR-TKI TREATMENT FOR ADVANCED NON-SMALL CELL LUNG CANCER Chen, Rui;Bai, Hua;Wang, Shuhang;Wang, Yuyan;Duan, Jianchun;Wang, Jie;An, Tongtong;Zhuo, Minglei;Wu, Meina
5-May-2021 Efficacy and Safety of Combination Treatment With Apatinib and Osimertinib After Osimertinib Resistance in Epidermal Growth Factor Receptor-Mutant Non-small Cell Lung Carcinoma-A Retrospective Analysis of a Multicenter Clinical Study Yang, Xue;Xia, Yang;Xu, Liyan;Liang, Li;Zhuo, Minglei;Wu, Meina;An, Tongtong;Wang, Ziping;Wang, Yuyan;Li, Jianjie;Zhong, Jia;Chen, Hanxiao;Jia, Bo;Wang, Jingjing;Zhao, Jun
2015 Efficacy and Safety of Weekly Albumin-Bound Paclitaxel for Non-Small-Cell Lung Cancer Patients Who Have Failed >= 2 Prior Systemic Regimens Wang, Jie;Duan, Jianchun;Hao, Yueqin;Zhao, Jun;Wang, Zhijie;An, Tongtong;Wu, Meina
2012 EGFR variant III expression in Chinese patients with non-small cell lung cancer. Wang, Jie;Duan, Jianchun;Bai, Hua;Yang, Lu;An, Tongtong;Wang, Zhijie;Zhuo, Minglei
2012 EGFR-TKI benefit for NSCLC patients with EML4-ALK rearrangement Wang, Zhijie;Wang, Jie;Wu, Yi Long;Bai, Hua;Zhang, Xu-Chao;An, Tongtong;Zhuo, Minglei;Duan, Jianchun;Yang, Lu;Wu, Meina
2012 EML4-ALK Rearrangement and Its Clinical Significance in Chinese Patients with Advanced Non-Small Cell Lung Cancer Wang, Zhijie;Zhang, Xuchao;Bai, Hua;Zhao, Jun;Zhuo, Minglei;An, Tongtong;Duan, Jianchun;Yang, Lu;Wu, Meina;Wang, Shuhang;Wang, Yuyan;Wu, Yilong;Wang, Jie
2015 Epidermal growth factor receptor variant III mutation in Chinese patients with squamous cell cancer of the lung Duan, Jianchun;Wang, Zhijie;Bai, Hua;An, Tongtong;Zhuo, Minglei;Wu, Meina;Wang, Yuyan;Yang, Lu;Wang, Jie
2015 Establishment of Lung Cancer Xenograft Models Derived from Bronchoscopy Biopsy and Investigating Mechanism of Refractory Small Cell Lung Cancer Wang, Jie;Fu, Shuai;Zhao, Jun;An, Tongtong;Bai, Hua;Duan, Jianchun;Wang, Zhijie
Showing results 1 to 20 of 59 next >